设为首页收藏本站
开启辅助访问 切换到窄版

 找回密码
 To register

QQ登录

只需一步，快速开始

扫一扫，访问微社区

  • ALL
  • Journals
  • Books

派博传思国际中心 »期刊书目

› Journal of SCIE
› PHARMACOLOGY & PHARMACY(药理学与药学)

1234下一页
返回列表

SCIE期刊Expert Opinion On Drug Safety 2024/2025影响因子:3.129 (EXPERT OPIN DRUG SAF) (1474-0338). (PHARMACOLOGY & PHARMACY)(药

[复制链接]
查看: 10863|回复: 35
发表于 2025-3-21 16:04:45 | 显示全部楼层 |阅读模式
期刊全称Expert Opinion On Drug Safety
期刊简称EXPERT OPIN DRUG SAF
影响因子20243.129
视频video
ISSN1474-0338
eISSN1744-764X
出版商TAYLOR & FRANCIS LTD
发行地址2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN
学科分类1.Science Citation Index Expanded (SCIE)--Pharmacology & Pharmacy; 2.Essential Science Indicators--Pharmacology & Toxicology;
出版语言English
The information of publication is updating

SCIE(SCI)期刊Expert Opinion On Drug Safety(20 21 REV HIST)影响因子


SCIE(SCI)期刊Expert Opinion On Drug Safety(EXPERT OPIN DRUG SAF)影响因子@(药理学与药学)学科排名


SCIE(SCI)期刊Expert Opinion On Drug Safety(20 21 REV HIST)总引论文


SCIE(SCI)期刊Expert Opinion On Drug Safety(EXPERT OPIN DRUG SAF)总引论文@(药理学与药学)学科排名


SCIE(SCI)期刊Expert Opinion On Drug Safety(20 21 REV HIST)影响因子


SCIE(SCI)期刊Expert Opinion On Drug Safety(EXPERT OPIN DRUG SAF)总引频次@(药理学与药学)学科排名


SCIE(SCI)期刊Expert Opinion On Drug Safety(20 21 REV HIST)即时影响因子


SCIE(SCI)期刊Expert Opinion On Drug Safety(EXPERT OPIN DRUG SAF)即时影响因子@(药理学与药学)学科排名


SCIE(SCI)期刊Expert Opinion On Drug Safety(20 21 REV HIST)五年累积影响因子


SCIE(SCI)期刊Expert Opinion On Drug Safety(EXPERT OPIN DRUG SAF)五年累积影响因子@(药理学与药学)学科排名


单选投票, 共有 0 人参与投票
1.jpg
 

0票 0%

Perfect with Aesthetics
2.jpg
 

0票 0%

Better Implies Difficulty
3.jpg
 

0票 0%

Good and Satisfactory
4.jpg
 

0票 0%

Adverse Performance
5.jpg
 

0票 0%

Disdainful Garbage
您所在的用户组没有投票权限
postpartum
回复

举报

发表于 2025-3-21 20:13:19 | 显示全部楼层
Submitted on: 06 March 2015. Revised on: 25 April 2015. Accepted on: 06 May 2015. ___________________Expert Opinion On Drug Safety---TAYLOR & FRANCIS LTD
Affection
回复

举报

发表于 2025-3-22 03:13:00 | 显示全部楼层
常到
回复

举报

发表于 2025-3-22 08:20:49 | 显示全部楼层
Submitted on: 07 December 2000. Revised on: 05 February 2001. Accepted on: 13 March 2001. ___________________Expert Opinion On Drug Safety---TAYLOR & FRANCIS LTD
猛然一拉
回复

举报

发表于 2025-3-22 10:21:49 | 显示全部楼层
Submitted on: 18 October 2018. Revised on: 23 December 2018. Accepted on: 17 February 2019. ___________________Expert Opinion On Drug Safety---TAYLOR & FRANCIS LTD
澄清
回复

举报

发表于 2025-3-22 15:30:25 | 显示全部楼层
Submitted on: 17 April 2011. Revised on: 22 July 2011. Accepted on: 03 August 2011. ___________________Expert Opinion On Drug Safety---TAYLOR & FRANCIS LTD
persistence
回复

举报

发表于 2025-3-22 17:57:41 | 显示全部楼层
Coronary
回复

举报

发表于 2025-3-23 00:35:12 | 显示全部楼层
diskitis
回复

举报

发表于 2025-3-23 01:21:57 | 显示全部楼层
JIBE
回复

举报

发表于 2025-3-23 05:58:38 | 显示全部楼层
Submitted on: 06 January 2020. Revised on: 04 February 2020. Accepted on: 31 March 2020. ___________________Expert Opinion On Drug Safety---TAYLOR & FRANCIS LTD
摊位
回复

举报

下一页 »
1234下一页
返回列表
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 18:20
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表